ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,966, issued on Oct. 6, was assigned to Beren Therapeutics P.B.C. (Thousand Oaks, Calif.).

"Methods for the treatment of cholesterol crystal embolization with cyclodextrins" was invented by Diana Kerwin (West Hollywood, Calif.) and Jason Camm (West Hollywood, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for reducing an amount of and/or a size of, and/or changing the shape of circulating (e.g., blood, serum, plasma) cholesterol crystals (and/or clots comprising cholesterol crystals) in an individual. Further disclosed herein are methods of treating cholesterol crystal embolization (CCE) and/or a symptom thereof in ...